Article Details

BridgeBio Pharma Shares Positive Results of Single-Arm Phase 3 Study of Acoramidis ... - BioSpace

Retrieved on: 2024-02-02 13:51:47

Tags for this article:

Click the tags to see associated articles and topics

BridgeBio Pharma Shares Positive Results of Single-Arm Phase 3 Study of Acoramidis ... - BioSpace. View article details on HISWAI: https://www.biospace.com/article/releases/bridgebio-pharma-shares-positive-results-of-single-arm-phase-3-study-of-acoramidis-in-japanese-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm-including-no-mortality-reported-in-the-trial-at-30-months/

Excerpt

... Alexion, AstraZeneca Rare Disease. Results showed consistency to those in the global BridgeBio ATTRibute-CM Phase III trial (NCT03860935) ...

Article found on: www.biospace.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up